Physician profile
Debbie Christensen
NPI 1306042296
$963.96
in general payments reported to CMS, 2019-2025
13 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $51.80 · 2021: $90.30 · 2022: $420 · 2023: $37.69 · 2024: $78.08 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $298.57 | 2019-2022 | |
| Genzyme Corporation | $166.77 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $150.32 | 2022-2024 | Dupixent |
| Glaxosmithkline, LLC. | $143.07 | 2022-2025 | Nucala |
| Optinose US, INC. | $69.83 | 2019-2021 | |
| Covidien LP | $20.20 | 2019 | |
| Medtronic, INC. | $18.29 | 2024 | Sinuva |
| Stryker Corporation | $18.24 | 2019 | |
| Kaleo, INC. | $17.66 | 2020 | |
| Baxter Healthcare | $16.50 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $15.98 | 2022 | |
| Davol INC. | $15.51 | 2021 | |
| Smith+Nephew, INC. | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debbie Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.